TBI |
MCC950; JC124; Gene knockout |
NLRP3 |
Reduce protein expression levels of NLRP3, ASC, IL-1 beta, inhibit pyrolysis, and reduce brain damage |
Kuwar et al. (2019), Ismael et al. (2018)
|
CORM-3 |
NLRP3/GSDMD/Cleaved caspase-1 |
Effectively resist neuroinflammation, inhibit pyroptosis, and improve prognosis |
Zhang et al. (2021)
|
Rhein |
Caspase-1/GSDMD/IL-1β/IL-18 |
Inhibit TBI-induced neuronal pyrolysis to alleviate neurological deficits. |
Bi et al. (2020)
|
siRNA knockdown and VX-765 |
Caspase-1 |
Ablation of caspase-1 can inhibit TBI-induced pyrolysis and nerve function damage |
Liu et al. (2018)
|
Ac-YVAD-cmk |
Caspase-1; NLRs and AIM2 inflammasome |
Inhibition of caspase-1 blocks the assembly of NLRs and AIM2 inflammasomes, thereby inhibiting pyrolysis |
Ge et al. (2018)
|
SCI |
BAY87-2243; MK2206 |
HIF-1α inhibitor; AKT inhibitor |
CD73 exerts an anti-pyroptosis effect in SCI through PI3K-AKT-Foxo1 signaling pathway |
Xu et al. (2021)
|
A438079 |
P2X7R and Caspase-1 |
Inhibition of P2X7R activation further inhibits caspase-1 activation and promotes the functional recovery of mice after SCI |
Jiang W et al. (2017), Wang et al. (2015)
|
Celastrol; kaempferol |
Inflammation and pyroptosis |
Celastrol and kaempferol exerts a neuroprotective effect by inhibiting the inflammation caused by microglia pyrolysis and excessive activation after SCI |
Dai et al. (2019), Liu Z et al. (2021)
|
Wogonoside |
NF-kB/TLR4 |
Reduces neuronal loss and pyroptosis; Improves functional recovery. |
Zhu et al. (2017)
|
Quercetin |
NLRP3/IL-1b/IL-18 |
Inhibit pyroptosis, promote neuroprotective axon regeneration, and promote neurological rehabilitation |
Jiang et al. (2016)
|